In this episode, we are joined by two lymphoma experts - Victoria Nachar, PharmD, BCOP and Tycel Phillips MD - to discuss the use of bispecific antibodies in Diffuse Large B-Cell Lymphoma (DLBCL)! Stay tuned for an exciting episode where we discuss the data, their possible role in therapy, and what questions and controversies remain.

Relevant Articles:

Review on Design of Bispecifics - https://pubmed.ncbi.nlm.nih.gov/25728220/

Epcoritamab - https://pubmed.ncbi.nlm.nih.gov/36548927/

Glofitamab - https://pubmed.ncbi.nlm.nih.gov/36507690/

Mosunetuzumab - https://pubmed.ncbi.nlm.nih.gov/34914545/

Odronextamab - https://pubmed.ncbi.nlm.nih.gov/35366963/

CRS and ICANS grading - https://pubmed.ncbi.nlm.nih.gov/30592986/

Episode 12: Tinder for T Cells - Bispecifics in DLBCL